On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...